Artificial Intelligence in IVD - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509244202

Publication Date:

September 3, 2024

Pages:

108

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Artificial Intelligence in IVD was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence in IVD, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Artificial Intelligence in IVD by region & country, by Type, and by Application.
The Artificial Intelligence in IVD market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence in IVD.
麻豆原创 Segmentation
By Company
Biofourmis Singapore Pte. Ltd.
Freenome
IBM Watson Health
Maxwell Plus
Nikon Instruments
Paragon Genomics
Predicine
PredictImmune
Qiagen
Rady Children鈥檚 Institute for Genomic Medicine
Reliant Immune Diagnostics
Siemens Healthineers
Sysmex
Viome
Segment by Type:
Hardware
Software
Segment by Application
Cancer Diagnostics
Cardiac Disease Testing
Digital Pathology
Genetic Testing
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Artificial Intelligence in IVD manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Artificial Intelligence in IVD in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Artificial Intelligence in IVD in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Artificial Intelligence in IVD Product Introduction
1.2 Global Artificial Intelligence in IVD 麻豆原创 Size Forecast
1.3 Artificial Intelligence in IVD 麻豆原创 Trends & Drivers
1.3.1 Artificial Intelligence in IVD Industry Trends
1.3.2 Artificial Intelligence in IVD 麻豆原创 Drivers & Opportunity
1.3.3 Artificial Intelligence in IVD 麻豆原创 Challenges
1.3.4 Artificial Intelligence in IVD 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Artificial Intelligence in IVD Players Revenue Ranking (2023)
2.2 Global Artificial Intelligence in IVD Revenue by Company (2019-2024)
2.3 Key Companies Artificial Intelligence in IVD Manufacturing Base Distribution and Headquarters
2.4 Key Companies Artificial Intelligence in IVD Product Offered
2.5 Key Companies Time to Begin Mass Production of Artificial Intelligence in IVD
2.6 Artificial Intelligence in IVD 麻豆原创 Competitive Analysis
2.6.1 Artificial Intelligence in IVD 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Artificial Intelligence in IVD Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence in IVD as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hardware
3.1.2 Software
3.2 Global Artificial Intelligence in IVD Sales Value by Type
3.2.1 Global Artificial Intelligence in IVD Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Artificial Intelligence in IVD Sales Value, by Type (2019-2030)
3.2.3 Global Artificial Intelligence in IVD Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cancer Diagnostics
4.1.2 Cardiac Disease Testing
4.1.3 Digital Pathology
4.1.4 Genetic Testing
4.1.5 Others
4.2 Global Artificial Intelligence in IVD Sales Value by Application
4.2.1 Global Artificial Intelligence in IVD Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Artificial Intelligence in IVD Sales Value, by Application (2019-2030)
4.2.3 Global Artificial Intelligence in IVD Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Artificial Intelligence in IVD Sales Value by Region
5.1.1 Global Artificial Intelligence in IVD Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Artificial Intelligence in IVD Sales Value by Region (2019-2024)
5.1.3 Global Artificial Intelligence in IVD Sales Value by Region (2025-2030)
5.1.4 Global Artificial Intelligence in IVD Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Artificial Intelligence in IVD Sales Value, 2019-2030
5.2.2 North America Artificial Intelligence in IVD Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Artificial Intelligence in IVD Sales Value, 2019-2030
5.3.2 Europe Artificial Intelligence in IVD Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Artificial Intelligence in IVD Sales Value, 2019-2030
5.4.2 Asia Pacific Artificial Intelligence in IVD Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Artificial Intelligence in IVD Sales Value, 2019-2030
5.5.2 South America Artificial Intelligence in IVD Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Artificial Intelligence in IVD Sales Value, 2019-2030
5.6.2 Middle East & Africa Artificial Intelligence in IVD Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Artificial Intelligence in IVD Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Artificial Intelligence in IVD Sales Value
6.3 United States
6.3.1 United States Artificial Intelligence in IVD Sales Value, 2019-2030
6.3.2 United States Artificial Intelligence in IVD Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Artificial Intelligence in IVD Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Artificial Intelligence in IVD Sales Value, 2019-2030
6.4.2 Europe Artificial Intelligence in IVD Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Artificial Intelligence in IVD Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Artificial Intelligence in IVD Sales Value, 2019-2030
6.5.2 China Artificial Intelligence in IVD Sales Value by Type (%), 2023 VS 2030
6.5.3 China Artificial Intelligence in IVD Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Artificial Intelligence in IVD Sales Value, 2019-2030
6.6.2 Japan Artificial Intelligence in IVD Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Artificial Intelligence in IVD Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Artificial Intelligence in IVD Sales Value, 2019-2030
6.7.2 South Korea Artificial Intelligence in IVD Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Artificial Intelligence in IVD Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Artificial Intelligence in IVD Sales Value, 2019-2030
6.8.2 Southeast Asia Artificial Intelligence in IVD Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Artificial Intelligence in IVD Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Artificial Intelligence in IVD Sales Value, 2019-2030
6.9.2 India Artificial Intelligence in IVD Sales Value by Type (%), 2023 VS 2030
6.9.3 India Artificial Intelligence in IVD Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Biofourmis Singapore Pte. Ltd.
7.1.1 Biofourmis Singapore Pte. Ltd. Profile
7.1.2 Biofourmis Singapore Pte. Ltd. Main Business
7.1.3 Biofourmis Singapore Pte. Ltd. Artificial Intelligence in IVD Products, Services and Solutions
7.1.4 Biofourmis Singapore Pte. Ltd. Artificial Intelligence in IVD Revenue (US$ Million) & (2019-2024)
7.1.5 Biofourmis Singapore Pte. Ltd. Recent Developments
7.2 Freenome
7.2.1 Freenome Profile
7.2.2 Freenome Main Business
7.2.3 Freenome Artificial Intelligence in IVD Products, Services and Solutions
7.2.4 Freenome Artificial Intelligence in IVD Revenue (US$ Million) & (2019-2024)
7.2.5 Freenome Recent Developments
7.3 IBM Watson Health
7.3.1 IBM Watson Health Profile
7.3.2 IBM Watson Health Main Business
7.3.3 IBM Watson Health Artificial Intelligence in IVD Products, Services and Solutions
7.3.4 IBM Watson Health Artificial Intelligence in IVD Revenue (US$ Million) & (2019-2024)
7.3.5 Maxwell Plus Recent Developments
7.4 Maxwell Plus
7.4.1 Maxwell Plus Profile
7.4.2 Maxwell Plus Main Business
7.4.3 Maxwell Plus Artificial Intelligence in IVD Products, Services and Solutions
7.4.4 Maxwell Plus Artificial Intelligence in IVD Revenue (US$ Million) & (2019-2024)
7.4.5 Maxwell Plus Recent Developments
7.5 Nikon Instruments
7.5.1 Nikon Instruments Profile
7.5.2 Nikon Instruments Main Business
7.5.3 Nikon Instruments Artificial Intelligence in IVD Products, Services and Solutions
7.5.4 Nikon Instruments Artificial Intelligence in IVD Revenue (US$ Million) & (2019-2024)
7.5.5 Nikon Instruments Recent Developments
7.6 Paragon Genomics
7.6.1 Paragon Genomics Profile
7.6.2 Paragon Genomics Main Business
7.6.3 Paragon Genomics Artificial Intelligence in IVD Products, Services and Solutions
7.6.4 Paragon Genomics Artificial Intelligence in IVD Revenue (US$ Million) & (2019-2024)
7.6.5 Paragon Genomics Recent Developments
7.7 Predicine
7.7.1 Predicine Profile
7.7.2 Predicine Main Business
7.7.3 Predicine Artificial Intelligence in IVD Products, Services and Solutions
7.7.4 Predicine Artificial Intelligence in IVD Revenue (US$ Million) & (2019-2024)
7.7.5 Predicine Recent Developments
7.8 PredictImmune
7.8.1 PredictImmune Profile
7.8.2 PredictImmune Main Business
7.8.3 PredictImmune Artificial Intelligence in IVD Products, Services and Solutions
7.8.4 PredictImmune Artificial Intelligence in IVD Revenue (US$ Million) & (2019-2024)
7.8.5 PredictImmune Recent Developments
7.9 Qiagen
7.9.1 Qiagen Profile
7.9.2 Qiagen Main Business
7.9.3 Qiagen Artificial Intelligence in IVD Products, Services and Solutions
7.9.4 Qiagen Artificial Intelligence in IVD Revenue (US$ Million) & (2019-2024)
7.9.5 Qiagen Recent Developments
7.10 Rady Children鈥檚 Institute for Genomic Medicine
7.10.1 Rady Children鈥檚 Institute for Genomic Medicine Profile
7.10.2 Rady Children鈥檚 Institute for Genomic Medicine Main Business
7.10.3 Rady Children鈥檚 Institute for Genomic Medicine Artificial Intelligence in IVD Products, Services and Solutions
7.10.4 Rady Children鈥檚 Institute for Genomic Medicine Artificial Intelligence in IVD Revenue (US$ Million) & (2019-2024)
7.10.5 Rady Children鈥檚 Institute for Genomic Medicine Recent Developments
7.11 Reliant Immune Diagnostics
7.11.1 Reliant Immune Diagnostics Profile
7.11.2 Reliant Immune Diagnostics Main Business
7.11.3 Reliant Immune Diagnostics Artificial Intelligence in IVD Products, Services and Solutions
7.11.4 Reliant Immune Diagnostics Artificial Intelligence in IVD Revenue (US$ Million) & (2019-2024)
7.11.5 Reliant Immune Diagnostics Recent Developments
7.12 Siemens Healthineers
7.12.1 Siemens Healthineers Profile
7.12.2 Siemens Healthineers Main Business
7.12.3 Siemens Healthineers Artificial Intelligence in IVD Products, Services and Solutions
7.12.4 Siemens Healthineers Artificial Intelligence in IVD Revenue (US$ Million) & (2019-2024)
7.12.5 Siemens Healthineers Recent Developments
7.13 Sysmex
7.13.1 Sysmex Profile
7.13.2 Sysmex Main Business
7.13.3 Sysmex Artificial Intelligence in IVD Products, Services and Solutions
7.13.4 Sysmex Artificial Intelligence in IVD Revenue (US$ Million) & (2019-2024)
7.13.5 Sysmex Recent Developments
7.14 Viome
7.14.1 Viome Profile
7.14.2 Viome Main Business
7.14.3 Viome Artificial Intelligence in IVD Products, Services and Solutions
7.14.4 Viome Artificial Intelligence in IVD Revenue (US$ Million) & (2019-2024)
7.14.5 Viome Recent Developments
8 Industry Chain Analysis
8.1 Artificial Intelligence in IVD Industrial Chain
8.2 Artificial Intelligence in IVD Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Artificial Intelligence in IVD Sales Model
8.5.2 Sales Channel
8.5.3 Artificial Intelligence in IVD Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Biofourmis Singapore Pte. Ltd.
Freenome
IBM Watson Health
Maxwell Plus
Nikon Instruments
Paragon Genomics
Predicine
PredictImmune
Qiagen
Rady Children鈥檚 Institute for Genomic Medicine
Reliant Immune Diagnostics
Siemens Healthineers
Sysmex
Viome

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.